Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2019 | 03-2018 | 03-2017 | 03-2016 | 03-2015 | |
| Sales | 669,893 | 661,913 | 879,387 | 950,751 | 862,944 |
| Cost of Goods | 224,169 | 198,405 | 208,136 | 171,785 | 186,359 |
| Gross Profit | 445,724 | 463,508 | 671,251 | 778,966 | 676,585 |
| Operating Expenses | 149,700 | 160,903 | 156,436 | 165,283 | 149,313 |
| Operating Income | 296,193 | 303,010 | 514,951 | 614,468 | 527,631 |
| Other Income | 60,661 | -10,642 | 45,847 | 22,352 | 54,049 |
| Pre-tax Income | 356,854 | 292,368 | 560,798 | 636,820 | 581,680 |
| Income Tax | 74,732 | 81,954 | 103,780 | 95,313 | 96,059 |
| Net Income Continuous | 282,122 | 210,414 | 457,018 | 541,507 | 485,621 |
| Net Income Discontinuous | N/A | -335 | -352 | -236 | -787 |
| Minority Interests | 345 | -1,071 | 310 | 339 | 577 |
| Net Income | $281,777 | $211,150 | $456,356 | $540,932 | $484,257 |
| EPS Basic Total Ops | 7.23 | 5.26 | 11.05 | 12.62 | 11.31 |
| EPS Basic Continuous Ops | 7.24 | 5.24 | 11.07 | 12.64 | 11.34 |
| EPS Basic Discontinuous Ops | N/A | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Total Ops | 7.23 | 5.26 | 11.05 | 12.62 | 11.31 |
| EPS Diluted Continuous Ops | 7.24 | 5.24 | 11.07 | 12.64 | 11.34 |
| EPS Diluted Discontinuous Ops | N/A | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Before Non-Recurring Items | 7.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $314,790 | $319,506 | $529,780 | $629,316 | $543,429 |